LSP 7 Cooperative UA 4
4 · Evommune, Inc. · Filed Feb 19, 2026
Research Summary
AI-generated summary of this filing
Evommune (EVMN) 10% Holder LSP 7 Receives Award of 358,680 Shares
What Happened LSP 7 Cooperatief UA, which holds a reported 10% stake in Evommune (EVMN), received an award of 358,680 shares of common stock on February 17, 2026. The shares were recorded at $27.88 per share, for a total reported value of $9,999,998. The transaction is coded as an award/grant (A) — an acquisition rather than an open-market purchase.
Key Details
- Transaction date: 2026-02-17; Form 4 filed: 2026-02-19.
- Shares acquired: 358,680 at $27.88 per share; total value $9,999,998.
- Shares owned after transaction: not specified in the filing.
- Footnote: Securities are held of record by LSP 7 Cooperatief UA. LSP 7 Management B.V. is the sole director; its managing directors are Martijn Kleijwegt, Rene Kuijten and Joachim Rothe, who may be deemed to share beneficial ownership but each disclaims beneficial ownership.
- Filing timeliness: filing date is two days after the transaction date (within the typical 2-business-day Form 4 window).
Context This was an institutional award to a 10% record holder rather than an executive buy or sale. Awards/grants can reflect financing arrangements, compensation, or contractual issuances and do not by themselves signal insider trading intent. The footnote indicates an institutional holding structure and names managers who may be deemed to share beneficial ownership but disclaim it.
Insider Transaction Report
- Award
Common Stock
[F1]2026-02-17$27.88/sh+358,680$9,999,998→ 5,288,313 total(indirect: See footnote)
Footnotes (1)
- [F1]Securities held of record by LSP 7 Cooperatief UA ("LSP 7"). LSP 7 Management B.V. is the sole director of LSP 7. The managing directors of LSP 7 Management B.V. are Martijn Kleijwegt, Rene Kuijten and Joachim Rothe. As such, LSP 7 Management B.V., Martijn Kleijwegt, Rene Kuijten and Joachim Rothe may be deemed to share beneficial ownership of the shares of Common Stock held by LSP 7. Each of Mr. Kleijwegt, Mr. Kuijten and Mr. Rothe disclaims beneficial ownership of such shares.